A rare cause of cyanosis and hypoxia that should not be forgotten after implantable cardioverter defibrillator implantation

CANPOLAT, UĞUR; Bahadir, NİHAN; Sahiner, Levent; AYTEMİR, KUDRET

doi:10.5543/tkda.2017.34801

A rare cause of cyanosis and hypoxia that should not be forgotten after implantable cardioverter defibrillator implantation

Atıf İçin Kopyala

CANPOLAT U., Bahadir N., Sahiner L., AYTEMİR K.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.45, sa.6, ss.560-562, 2017 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 45 Sayı: 6
Basım Tarihi: 2017
Doi Numarası: 10.5543/tkda.2017.34801
Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.560-562
Anahtar Kelimeler: Cardiovascular electronic device, complication, methemoglobinemia
Hacettepe Üniversitesi Adresli: Evet

Özet

Transvenous pacemaker or implantable cardio-verter defibrillator (ICD) implantation procedures are usually performed under local anesthetic, and prilocaine is the most common agent to be used. The data regarding methemoglobinemia after cardiac device implantation are scarce. Thus, presently described is the case of a 47-year-old female patient with arrhythmogenic right ventricular cardiomyopathy/dysplasia who underwent ICD implantation for secondary prophylaxis and developed cyanosis as a result of prilocaine-associated methemoglobinemia. Prilocaine was administered during the procedure. To our knowledge, this is the second case in the literature presenting methemoglobinemia due to local anesthetic after transvenous cardiac device implantation.